New scaffold could help heal torn ACLs without full reconstruction
NCT ID NCT02292004
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests a new device called the MIACH scaffold, which is placed inside a torn anterior cruciate ligament (ACL) to help it heal. Twenty people with complete ACL tears will take part: half will get the scaffold plus standard repair, and half will get standard ACL reconstruction. The main goal is to check if the scaffold is safe and well-tolerated.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- MIACH scaffold (BEAR Implant)
- What this could lead to
- If it works, this could offer a way to repair a torn ACL instead of replacing it, potentially leading to better long-term knee function.
- What could go wrong
- This is a very small, early safety study with only 20 participants. The new device may not heal the ligament as well as standard surgery, and there are risks like infection or rejection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTERIOR CRUCIATE LIGAMENT INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Children's Hospital
Boston, Massachusetts, 02115, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can the ankle fully recover after donating a tendon for ACL repair?
- Can a 3D-Printed gadget speed up knee recovery?
- Mind over knee: can psychological readiness predict a safe return to sport after ACL surgery?
- Which ACL graft gets young athletes back in the game faster?
- Extra nerve block may ease pain after ACL repair
- Vibration therapy may reduce second ACL injury risk